During the ATS 2023 Respiratory Innovation Summit, APIE Therapeutics presented a poster demonstrating preclinical efficacy of APT101 in a lung fibrosis model
| Date/Time: | May 20, 2023 |
| Title: | Apelin/APJ Agonists as a Novel Therapeutic Target for Lung Fibrosis Upstream and Downstream of Disease Pathophysiology |
| Authors: | Willette RN1, Alegria E1, Runyon S2, Maitra R2 |
| 1) APIE-Therapeutics Inc. 2) Research Triangle Park |
